tradingkey.logo

Alcon AG

ALC
77.360USD
+2.970+3.99%
終値 11/11, 16:00ET15分遅れの株価
38.26B時価総額
35.66直近12ヶ月PER

Alcon AG

77.360
+2.970+3.99%

詳細情報 Alcon AG 企業名

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Alcon AGの企業情報

企業コードALC
会社名Alcon AG
上場日Apr 09, 2019
最高経営責任者「CEO」Mr. David J. Endicott
従業員数25599
証券種類Ordinary Share
決算期末Apr 09
本社所在地Rue Louis d'Affry 6
都市FRIBOURG
証券取引所SIX Swiss Exchange
Switzerland
郵便番号1700
電話番号41589113800
ウェブサイトhttps://www.alcon.ch/
企業コードALC
上場日Apr 09, 2019
最高経営責任者「CEO」Mr. David J. Endicott

Alcon AGの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
事業別USD
会社名
収益
比率
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
地域別USD
会社名
収益
比率
International
1.42B
54.99%
United States
1.16B
45.01%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%

株主

更新時刻: Fri, Aug 15
更新時刻: Fri, Aug 15
株主統計
種類
株主統計
株主統計
比率
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
他の
83.89%
株主統計
株主統計
比率
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
他の
83.89%
種類
株主統計
比率
Investment Advisor
32.72%
Investment Advisor/Hedge Fund
25.40%
Bank and Trust
4.40%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.18%
Research Firm
1.75%
Pension Fund
1.51%
Individual Investor
0.13%
Insurance Company
0.09%
他の
29.47%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1625
347.92M
69.62%
-14.37M
2025Q2
1631
340.08M
68.06%
-38.93M
2025Q1
1659
342.42M
68.52%
-42.21M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Harding Loevner LP
7.01M
1.4%
-117.33K
-1.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Global X Aging Population ETF
2.3%
Franklin FTSE Switzerland ETF
2.29%
iShares MSCI Switzerland ETF
2.14%
Running Oak Efficient Growth ETF
1.75%
First Trust Indxx Medical Devices ETF
1.6%
Global X S&P Catholic Values Developed ex-US ETF
0.98%
First Trust Switzerland Alphadex Fund
0.68%
iShares Global Healthcare ETF
0.52%
ALPS O'Shares International Developed Quality Dividend ETF
0.48%
Wahed Dow Jones Islamic World ETF
0.44%
詳細を見る
Global X Aging Population ETF
比率2.3%
Franklin FTSE Switzerland ETF
比率2.29%
iShares MSCI Switzerland ETF
比率2.14%
Running Oak Efficient Growth ETF
比率1.75%
First Trust Indxx Medical Devices ETF
比率1.6%
Global X S&P Catholic Values Developed ex-US ETF
比率0.98%
First Trust Switzerland Alphadex Fund
比率0.68%
iShares Global Healthcare ETF
比率0.52%
ALPS O'Shares International Developed Quality Dividend ETF
比率0.48%
Wahed Dow Jones Islamic World ETF
比率0.44%

配当金

過去5年間の配当金総支払額は 400.00M 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI